{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:06:43Z","timestamp":1785546403809,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.healun.2016.03.021","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:26:48Z","timestamp":1459556808000},"page":"962-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Desensitization strategies in adult heart transplantation\u2014Will persistence pay off?"],"prefix":"10.1016","volume":"35","author":[{"given":"Sharon","family":"Chih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-6750","authenticated-orcid":false,"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.03.021_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report\u20142014; Focus theme: retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib3","first-page":"229","article-title":"Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant","volume":"6","author":"Kaczmarek","year":"2008","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.03.021_bib5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-6143.2009.02612.x","article-title":"Mechanisms of alloantibody production in sensitized renal allograft recipients","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib6","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.healun.2016.03.021_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12011","article-title":"The establishment of the plasma cell survival niche in the bone marrow","volume":"251","author":"Chu","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.healun.2016.03.021_bib8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib9","first-page":"2019","article-title":"Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation","volume":"150","author":"Kilgore","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2016.03.021_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trre.2009.02.005","article-title":"Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.healun.2016.03.021_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/iai.11.3.488-492.1975","article-title":"Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity","volume":"11","author":"Snyderman","year":"1975","journal-title":"Infect Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4049\/jimmunol.163.2.1010","article-title":"Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha","volume":"163","author":"Bian","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0198-8859(96)00272-8","article-title":"Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation","volume":"53","author":"Bian","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib14","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.4049\/jimmunol.159.11.5697","article-title":"Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis","volume":"159","author":"Harris","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib15","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.180.4.2357","article-title":"HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway","volume":"180","author":"Jindra","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib16","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.athoracsur.2011.07.082","article-title":"Impact of virtual cross match on waiting times for heart transplantation","volume":"92","author":"Yanagida","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.03.021_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.healun.2009.05.031","article-title":"Utility of virtual crossmatch in sensitized patients awaiting heart transplantation","volume":"28","author":"Stehlik","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.5858\/2009-0581-OA.1","article-title":"Antihuman leukocyte antigen-specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches","volume":"134","author":"Batal","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.healun.2016.03.021_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2014a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.healun.2014.02.013","article-title":"Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation","volume":"33","author":"Oaks","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2016.03.021_bib23","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/01.tp.0000231447.34240.3c","article-title":"Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration","volume":"82","author":"Jindra","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib28","first-page":"416","article-title":"B-cell immunotherapeutics: emerging roles in solid organ transplantation. Curr Opin","volume":"16","author":"Jordan","year":"2011","journal-title":"Organ Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2016.03.021_bib33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib34","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","article-title":"The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation","volume":"90","author":"Flechner","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TP.0b013e31824612df","article-title":"Durability of antibody removal following proteasome inhibitor-based therapy","volume":"93","author":"Everly","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/TP.0000000000000132","article-title":"Differential effect of bortezomib on HLA class I and class II antibody","volume":"98","author":"Philogene","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib38","first-page":"229","article-title":"Changes in IgG subclasses of donor specific anti-HLA antibodies following bortezomib-based therapy for antibody mediated rejection","author":"Kannabhiran","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.healun.2015.01.982","article-title":"Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation","volume":"34","author":"Khuu","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib40","first-page":"306","article-title":"Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"165","author":"Wong","year":"2015","journal-title":"Transpl Res"},{"key":"10.1016\/j.healun.2016.03.021_bib41","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib45","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.03.021_bib47","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2016.03.021_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/circ.100.suppl_2.Ii-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.03.021_bib51","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0041-1345(98)00172-9","article-title":"Use of intravenous immunoglobulin in sensitized LVAD recipients","volume":"30","author":"Dowling","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.03.021_bib52","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long-term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2016.03.021_bib54","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.healun.2015.01.072","article-title":"Plasmapheresis and bortezomib for sensitized patients awaiting heart transplantation\u2014worth the effort?","volume":"34","author":"Patel","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib55","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 9","key":"10.1016\/j.healun.2016.03.021_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.17.s9.3.x","article-title":"Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients","volume":"17","author":"Leech","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","article-title":"Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation","volume":"18","author":"Pisani","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in sensitized lung transplant recipients with perioperative desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.transproceed.2011.12.028","article-title":"Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation","volume":"44","author":"Jordan","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.03.021_bib60","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2016.03.021_bib61","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.healun.2015.01.073","article-title":"terminal complement inhibition for highly sensitized patients undergoing heart transplantation\u2014doable?","volume":"34","author":"Patel","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.03.021_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0966-3274(93)90060-L","article-title":"The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart\u2013lung transplantation","volume":"1","author":"Smith","year":"1993","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2016.03.021_bib63","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.03.021_bib64","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/ajt.12636","article-title":"Antibody desensitization therapy in highly sensitized lung transplant candidates","volume":"14","author":"Snyder","year":"2014","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816300742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816300742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:32:27Z","timestamp":1760949147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816300742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1053249816300742"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.03.021","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desensitization strategies in adult heart transplantation\u2014Will persistence pay off?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}